Tiep Tien Nguyen

Tiep Tien Nguyen

Auto-generated profile, based on publicly available information

Tiep Tien Nguyen

Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon, Republic of Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2020 in Cells
Verified
Journal Article
Open access
PDF file
DCDinh-Toi Chu
Dinh-Toi Chu
TNTiep Tien Nguyen
Tiep Tien Nguyen
NTNguyen Le Bao Tien
Nguyen Le Bao Tien
Khoa TranKhoa Tran
Khoa Tran
JJJee-Heon Jeong
Jee-Heon Jeong
TDThien Chu Dinh
Thien Chu Dinh
The insufficient and unspecific target of traditional therapeutic approaches in cancer treatment often leads to therapy resistance and cancer recurrence. Over the past decades, accumulating discoveries about stem cell biology have provided new potential approaches to cure cancer patients. Stem cells possess unique biological actions, including self-renewal, directional migration, differentiation, and modulatory effects on other cells, which can be utilized as regenerative medicine, therapeutic carriers, drug targeting, and generation of immune cells. In this review, we emphasize the mechanisms underlying the use of various types of stem cells in cancer treatment. In addition, we summarize recent progress in the clinical applications of stem cells, as well as common risks of this therapy. We finally give general directions for future studies, aiming to improve overall outcomes in the fight against cancer.

26 August 2022 in Science Advances
Verified
Journal Article
Open access
TNTiep Tien Nguyen
Tiep Tien Nguyen
DPDuc-Vinh Pham
Duc-Vinh Pham
JPJunhyeung Park
Junhyeung Park
CPCao Dai Phung
Cao Dai Phung
MNMahesh Nepal
Mahesh Nepal
JJJee-Heon Jeong
Jee-Heon Jeong
Immunomodulation is an essential consideration for cell replacement procedures. Unfortunately, lifelong exposure to nonspecific systemic immunosuppression results in immunodeficiency and has toxic effects on nonimmune cells. Here, we engineered hybrid spheroids of mesenchymal stem cells (MSCs) with rapamycin-releasing poly(lactic- co -glycolic acid) microparticles (RAP-MPs) to prevent immune rejection of islet xenografts in diabetic C57BL/6 mice. Hybrid spheroids were rapidly formed by incubating cell-particle mixture in methylcellulose solution while maintaining high cell viability. RAP-MPs were uniformly distributed in hybrid spheroids and sustainably released RAP for ~3 weeks. Locoregional transplantation of hybrid spheroids containing low doses of RAP-MPs (200- to 4000-ng RAP per recipient) significantly prolonged islet survival times and promoted the generation of regional regulatory T cells. Enhanced programmed death-ligand 1 expression by MSCs was found to be responsible for the immunomodulatory performance of hybrid spheroids. Our results suggest that these hybrid spheroids offer a promising platform for the efficient use of MSCs in the transplantation field.

21 March 2021 in Molecules
Verified
Journal Article
Open access
PDF file
PTpunam thapa
punam thapa
YLYoo Jin Lee
Yoo Jin Lee
TNTiep Tien Nguyen
Tiep Tien Nguyen
DPDonglan Piao
Donglan Piao
HLHwaryeong Lee
Hwaryeong Lee
Eun Kyoung SeoEun Kyoung Seo
Eun Kyoung Seo
Alpinia oxyphylla Miquel (Zingiberaceae) has been reported to show antioxidant, anti-inflammatory, and neuroprotective effects. In this study, two new eudesmane sesquiterpenes, 7α-hydroperoxy eudesma-3,11-diene-2-one (1) and 7β-hydroperoxy eudesma-3,11-diene-2-one (2), and a new eremophilane sesquiterpene, 3α-hydroxynootkatone (3), were isolated from the MeOH extract of dried fruits of A. oxyphylla along with eleven known sesquiterpenes (4–14). The structures were elucidated by the analysis of 1D/2D NMR, high-resolution electrospray ionization mass spectrometry (HRESIMS), and optical rotation data. Compounds (1–3, 5–14) were evaluated for their protective effects against tert-butyl hydroperoxide (tBHP)-induced oxidative stress in adipose-derived mesenchymal stem cells (ADMSCs). As a result, treatment with isolated compounds, especially compounds 11 and 12, effectively reverted the damage of tBHP on ADMSCs in a dose-dependent manner. In particular, 11 and 12 at 50 µM improved the viability of tBHP-toxified ADMSCs by 1.69 ± 0.05-fold and 1.61 ± 0.03-fold, respectively.

16 October 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SRShobha Regmi
Shobha Regmi
SPShiva Pathak
Shiva Pathak
TTTung Pham Thanh
Tung Pham Thanh
TNTiep Tien Nguyen
Tiep Tien Nguyen
JSJong-Hyuk Sung
Jong-Hyuk Sung
JJJee-Heon Jeong
Jee-Heon Jeong
Background: Systemic inflammatory response syndrome (SIRS) is common in severe fulminant hepatic failure (FHF) and has a high mortality rate (20–50%) due to irreversible cerebral edema or sepsis. Stem cell-based treatment has emerged as a promising alternative therapeutic strategy to prolong the survival of patients suffering from FHF via the inhibition of SIRS due to their immunomodulatory effects.Methods: 3D spheroids of adipose-derived mesenchymal stem cells (3D-ADSC) were prepared by the hanging drop method. The efficacy of the 3D-ADSC to rescue FHF was evaluated in ad-galactosamine/lipopolysaccharide (GalN/LPS)-induced mouse model of FHF via intraportal transplantation of the spheroids.Results: Intraportally delivered 3D-ADSC better engrafted and localized into the damaged livers compared to 2D-cultured adipose-derived mesenchymal stem cells (2D-ADSC). Transplantation of 3D-ADSC rescued 50% of mice from FHF-induced lethality, whereas only 20% of mice survived when 2D-ADSC were transplanted. The improved transplantation outcomes correlated with the enhanced immunomodulatory effect of 3D-ADSC in the liver microenvironment.Conclusion: The study shows that the transplantation of optimized 3D-ADSC can efficiently ameliorate GalN/LPS-induced FHF due to improved viability, resistance to exogenous ROS, and enhanced immunomodulatory effects of 3D-ADSC.

30 September 2024 in International Journal of Surgery
Verified
Journal Article
Open access
SLSang-Oh Lee
Sang-Oh Lee
BPBo-Yoon Park
Bo-Yoon Park
TNTiep Tien Nguyen
Tiep Tien Nguyen
KKKyoo-Ri Kwon
Kyoo-Ri Kwon
MKMi-Jin Kim
Mi-Jin Kim
IKIl-Kug Kim
Il-Kug Kim
An abstract is unavailable. This article is available as a PDF only.

29 June 2026 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
TNTiep Tien Nguyen
Tiep Tien Nguyen
NNNhu-Nam Nguyen
Nhu-Nam Nguyen
LNLinh Nguyen
Linh Nguyen
KPKim-Phuong Phan
Kim-Phuong Phan
JPJunhyeung Park
Junhyeung Park
JJJee-Heon Jeong
Jee-Heon Jeong